For research use only. Not for therapeutic Use.
Didesmethyl cariprazine is a metabolite of Cariprazine and acts as the predominant circulating active moiety. Didesmethyl cariprazine has a long half-life of 1-3 weeks. Cariprazine is a antipsychotic drug candidate that exhibits high affinity for the D3 and D2 receptors, and moderate affinity for the 5-HT1A receptor[1].
| Catalog Number | I017501 |
| CAS Number | 839712-25-3 |
| Molecular Formula | C₁₉H₂₈Cl₂N₄O |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| Reference | [1]. Citrome L, et al. Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy. Neuropsychiatr Dis Treat. 2018 Oct 5;14:2563-2577. |
